Pfizer Raises 2026 Revenue Outlook to as Much as $64 Billion After Q3 Beat. Pfizer posted third-quarter revenue of $16.6 billion and adjusted earnings of 87 cents a share, topping LSEG estimates of 73 cents, as revenue from its launched and acquired products grew 32%